Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE 01:30:02 02/09/2026 am IST			5-day change	1st Jan Change
380.96 ^USD	-1.34%		-2.40%	+25.73%

07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
05/08	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	1.01TCr	BBB	-
ABBOTT LABORATORIES	19TCr	BBB
MEDTRONIC PLC	12TCr	BBB
CENCORA, INC.	6.32TCr	AA
HOYA CORPORATION	5.2TCr	AAA
BECTON, DICKINSON AND COMPANY	5.1TCr	A
DEXCOM, INC.	3.4TCr	BBB
MEDLINE INC.	3.08TCr	A
WEST PHARMACEUTICAL SERVICES, INC.	2.38TCr	AA
TERUMO CORPORATION	2.34TCr	AA
STERIS PLC	2.24TCr	AAA	-
SARTORIUS STEDIM BIOTECH	2.2TCr	BBB
ZIMMER BIOMET HOLDINGS, INC.	1.9TCr	A
SOLVENTUM CORPORATION	1.55TCr	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	1.53TCr	A
BAXTER INTERNATIONAL INC.	1.32TCr	A
ALIGN TECHNOLOGY, INC.	1.1TCr	A
GLOBUS MEDICAL, INC.	1.08TCr	CCC
INSULET CORPORATION	1.03TCr	A
REPLIGEN CORPORATION	959.52Cr	AA
Average	3.72TCr	A
Weighted average by Cap.		A